(Fort Worth, Texas – April 25, 2008) Galderma, a worldwide leading
dermatological company, is proud to announce the April 25, 2008 groundbreaking
on a new 50,000-square-foot administrative office and in-house training
facility in Fort Worth, Texas. Galderma’s new facility will be located on 4.61
acres adjacent to its US headquarter facility at 14501 North Freeway. The
two-story, built-to-suit office building is expected to eventually house up to
100 additional employees. Construction is scheduled for completion January
2009. Galderma products treat major skin conditions such as acne, pigmentary
disorders, rosacea and psoriasis.
The new site will be equipped with office and conference room space.
Additionally, in-house training rooms will accommodate up to 100 staff members
for local and regional meetings. The building will also house additional
personnel in Galderma’s new aesthetics and correctives group. Galderma’s
current 50,000-square-foot building offices more than 140 Galderma employees.
The location also includes a 70,000-square-foot distribution center.
“Since the creation of Galderma in 1981 as a joint venture of Nestlé and
L'Oréal, all our resources have been channeled in a single direction: to
provide innovative therapeutic, corrective and aesthetic solutions that meet
the needs of dermatology patients and physicians,” said Albert Draaijer,
president of Galderma’s operations in North and South America. “This addition
to our Fort Worth campus will provide the facilities we need as our numbers
grow. With the recent acquisition of CollaGenex Pharmaceuticals, it’s more
important than ever to have this type of facility that can handle our needs.”
Duke Realty Corporation (Duke) was selected to construct the building for
Galderma. “We are honored to have been selected by Galderma for their new
facility,” said Blair Oden, Duke Realty vice president, leasing and
development. “Our proven track record as a company in developing office
properties, specifically those constructed to the client’s exacting
specifications and our reputation for professionalism enabled us to win the
trust of Galderma. We fully intend to develop a first-class facility for them
and move forward on this very exciting development for the north Fort Worth
market.”
About Galderma:
Galderma, created in 1981 as a joint venture between Nestlé and L'Oréal, is a
fully integrated specialty pharmaceutical company dedicated exclusively to
dermatology. The Company has a presence in 65 countries with over 1000 sales
representatives and is committed to improving the health of skin with an
extensive line of products that treat a range of dermatological conditions
including: acne, rosacea, fungal nail infections, psoriasis &
steroid-responsive dermatoses, pigmentary disorders, skin cancers and medical
solutions for skin senescence. Galderma’s research center in Sophia Antipolis,
France is the largest facility in the world dedicated to Research and
Development in dermatology. Galderma leading brands include Differin®,
Metro®/Rozex®, Oracea®, Clobex®, Tri-Luma®, Loceryl® and Cetaphil®. Recently
launched products include Pliaglis™, a topical anesthetic for dermatologic
procedures in the United States, Epiduo®, an innovative combination product for
the treatment of acne in Europe and Argentina and Dysport®, an injectable
neuro-modulator for the correction of wrinkles in Brazil and Argentina. The
Company’s website is www.galderma.com or for the U.S. www.galdermaUSA.com.